The Journal of experimental medicine

Entry of B cell receptor into signaling domains is inhibited in tolerant B cells.

The Journal of experimental medicine

Weintraub BC, Jun JE, Bishop AC, Shokat KM, Thomas ML, Goodnow CC

Turning on natural killer cells.

The Journal of experimental medicine

Lanier LL

Turning on natural killer cells.

The Journal of experimental medicine

Lanier LL

Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

The Journal of experimental medicine

Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA

Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

The Journal of experimental medicine

Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA

CD1, tuberculosis, and the evolution of major histocompatibility complex molecules.

The Journal of experimental medicine

Shinkai K, Locksley RM

CD1, tuberculosis, and the evolution of major histocompatibility complex molecules.

The Journal of experimental medicine

Shinkai K, Locksley RM

Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn.

The Journal of experimental medicine

Fitzer-Attas CJ, Lowry M, Crowley MT, Finn AJ, Meng F, DeFranco AL, Lowell CA

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.

The Journal of experimental medicine

Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.

The Journal of experimental medicine

Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP

Pages